423
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Does Antiretroviral Therapy Packaging Matter? Perceptions and Preferences of Antiretroviral Therapy Packaging for People Living with HIV in Northern Tanzania

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 153-161 | Published online: 23 Jan 2020

References

  • HIV/AIDS JUNPo. Miles to Go. Global AIDS Update 2018. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2018. Accessed December 14, 2108.
  • Tseng A, Seet J, Phillips EJ. The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future. Br J Clin Pharmacol. 2015;79(2):182–194. doi:10.1111/bcp.2015.79.issue-2
  • Scott Sutton S, Magagnoli J, Hardin JW. Impact of pill burden on adherence, risk of hospitalization, and viral suppression in patients with HIV infection and AIDS receiving antiretroviral therapy. Pharmacotherapy. 2016;36(4):385–401. doi:10.1002/phar.2016.36.issue-4
  • Kalichman SC, Mathews C, Banas E, Kalichman MO. Treatment adherence in HIV stigmatized environments in South Africa: stigma avoidance and medication management. Int J STD AIDS. 2018;30(4):362–370.
  • Knettel BA, Mulawa MI, Knippler ET, et al. Women’s perspectives on ImpACT: a coping intervention to address sexual trauma and improve HIV care engagement in Cape Town, South Africa. AIDS Care. 2019;1–8.
  • Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–1795. doi:10.1007/s10461-013-0437-9
  • Ramadhani HO, Muiruri C, Maro VP, et al. Patient-initiated repackaging of antiretroviral therapy, viral suppression and drug resistance. AIDS Behav. 2018;22(5):1671–1678. doi:10.1007/s10461-017-1721-x
  • Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT. Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria. AIDS Patient Care STDS. 2013;27(1):55–64. doi:10.1089/apc.2012.0150
  • Martin F, Kiwanuka T, Kawuma R, Zalwango F, Seeley J. Tasks and strategies of self-management of living with antiretroviral therapy in Uganda. AIDS Patient Care STDS. 2013;27(12):697–706. doi:10.1089/apc.2013.0254
  • Mutumba M, Bauermeister JA, Musiime V, et al. Psychosocial challenges and strategies for coping with HIV among adolescents in Uganda: a qualitative study. AIDS Patient Care STDS. 2015;29(2):86–94. doi:10.1089/apc.2014.0222
  • Zedler BK, Kakad P, Colilla S, Murrelle L, Shah NR. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Ther. 2011;33(1):62–73. doi:10.1016/j.clinthera.2011.02.003
  • Bosworth HB, Brown JN, Danus S, et al. Evaluation of a packaging approach to improve cholesterol medication adherence. Am J Manag Care. 2017;23(9):e280–e286.
  • Naidoo KK, Govender T, Deonunan RA, et al. Post-dispensing stability surveillance: stavudine. Afr J Prim Health Care Fam Med. 2009;1(1):014. doi:10.4102/phcfm.v1i1.14
  • Zadbuke N, Shahi S, Gulecha B, Padalkar A, Thube M. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioallied Sci. 2013;5(2):98–110. doi:10.4103/0975-7406.111820
  • Mahtani KR, Heneghan CJ, Glasziou PP, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011;9:Cd005025.
  • Andreu-Crespo A, Llibre JM, Cardona-Peitx G, Sala-Pinol F, Clotet B, Bonafont-Pujol X. Hidden costs of antiretroviral treatment: the public health efficiency of drug packaging. Drug Des Devel Ther. 2015;9:4287–4290. doi:10.2147/DDDT.S87075
  • Heneghan CJ, Glasziou P, Perera R. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2006;1:Cd005025.
  • Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc. 2008;48(1):58–63. doi:10.1331/JAPhA.2008.07040
  • Guest G, MacQueen KM, Namey EE. Applied Thematic Analysis. Thousand Oaks: SAGE; 2012.
  • Faasse K, Martin LR. The power of labeling in nocebo effects. Int Rev Neurobiol. 2018;139:379–406.
  • Guy Tiene. Pharmaceutical packaging: differentiation equates to brand loyalty pharmaceutical packaging web site; 2016. Available from: https://www.americanpharmaceuticalreview.com/Featured-Articles/239817-Pharmaceutical-Packaging-Differentiation-Equates-to-Brand-Loyalty/. Accessed Jun 18, 2019.
  • S ZC S, Shefer T, Temmerman M, Abrahams N. Intimate partner violence after disclosure of HIV test results among pregnant women in Harare, Zimbabwe. PLoS One. 2014;9(10):e109447. doi:10.1371/journal.pone.0109447
  • Knettel BA, Minja L, Chumba LN, et al. Serostatus disclosure among a cohort of HIV-infected pregnant women enrolled in HIV care in Moshi, Tanzania: a mixed-methods study. SSM Popul Health. 2018;15.
  • Maeri I, El Ayadi A, Getahun M, et al.; SEARCH Collaboration. How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial. AIDS Care. 2016;28:59–66. doi:10.1080/09540121.2016.1168917
  • Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(3 Suppl 2):18640. doi:10.7448/IAS.16.3.18640
  • Gutierrez PM, Wortzel HS, Forster JE, Leitner RA, Hostetter TA, Brenner LA. Blister packaging medication increases treatment adherence in psychiatric patients. J Psychiatr Pract. 2017;23(5):320–327. doi:10.1097/PRA.0000000000000252
  • Bruxvoort K, Festo C, Cairns M, et al. measuring patient adherence to malaria treatment: a comparison of results from self-report and a customised electronic monitoring device. PLoS One. 2015;10(7):e0134275. doi:10.1371/journal.pone.0134275